Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Winograd EJ, Sollee D, Schauben JL, Kunisaki T, Smotherman C, Gautam S. Pediatric guanfacine exposures reported to the National Poison Data System, 2000–2016. Clin Toxicol. 2020;58:49–55.
2. Bridwell RE, Larson NP, Rosenthal JB, Wray J, Baker Z, Cibrario A, et al. Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema. Am J Emerg Med. 2021;39:256.e5-256.e8.
3. Martinez-Raga J, Knecht C, Szerman N, Martinez MI. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs. 2013;27:15–30.
4. Martin P, Satin L, Kahn RS, Robinson A, Corcoran M, Purkayastha J, et al. A thorough QT study of guanfacine. Int J Clin Pharmacol Ther. 2014;53:301–16.
5. Schulz M, Schmoldt A, Andresen-Streichert H, Iwersen-Bergmann S. Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care. 2020;24:195.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献